Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Zymogenetics Inc
Zymogenetics Inc National Jewish Medical Research Center
Zymogenetics Inc_20100114
Zymogenetics Inc_20100121
Zymogenetics Inc_20131212
  

Zymogenetics Inc patents

Recent patent applications related to Zymogenetics Inc. Zymogenetics Inc is listed as an Agent/Assignee. Note: Zymogenetics Inc may have other listings under different names/spellings. We're not affiliated with Zymogenetics Inc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "Z" | Zymogenetics Inc-related inventors




Date Zymogenetics Inc patents (updated weekly) - BOOKMARK this page
09/28/17Homogeneous preparations of il-31
09/28/17Methods of treating skin disorders using anti-il-31ra antibodies
09/21/17Compositions and methods for modulating immune responses
09/14/17Methods of treating atopic dermatitis with il-31 monoclonal antibodies
08/17/17Methods of treating inflammation using il-17a and il-17f cross-reactive monoclonal antibodies
08/10/17Soluble hybrid fcgamma receptors and related methods
07/27/17Homogeneous preparations of il-28 and il-29
07/20/17Zcytor17 heterodimeric cytokine receptor monoclonal antibodies
07/06/17Use of il-31 monoclonal antibodies for treating neuronal inflammation
07/06/17Use of il-31ra monoclonal antibodies for treating neuronal inflammation
06/29/17Methods of treating atopic dermatitis with il-31 monoclonal antibodies
05/18/17Methods of treating skin disorders using an anti-il-31ra antibody
05/11/17Method of reducing pruritus using il-31 monoclonal antibodies
04/06/17Homogeneous preparations of il-31
04/06/17Methods of treating diseases which are mediated by cutaneous lymphocyte antigen positive cells
02/16/17Use of il-31 monoclonal antibodies for treating atopic dermatitis
02/09/17Anti-human il-21 antibodies
12/29/16Use of an il-17/il-23 bispecific antibody for treating inflammation
12/01/16Homogeneous preparations of il-31
10/27/16Monoclonal antibodies that bind both il-17a and il-17f
10/27/16Il-31 monoclonal antibody formulations
10/27/16Compositions and methods for inhibiting pdgfrbeta and vegf-a
08/04/16Use of an il-31 monoclonal antibody for antagonizing signal transduction in spinal cord cells
08/04/16Method treating neuronal tissue inflammation using an il-31ra monoclonal antibody
06/30/16Compositions and methods for modulating immune responses
03/03/16Zcytor17 heterodimeric cytokine receptor
02/25/16Combination of blys inhibition and anti-cd 20 agents for treatment of autoimmune disease
02/25/16Antibodies that bind both il-17a and il-17f and methods of using same
01/28/16Methods of treating diseases which are mediated by cutaneous lymphocyte antigen positive cells
01/07/16Zcytor17 heterodimeric cytokine receptor monoclonal antibodies
12/24/15Il-31 monoclonal antibodies
12/03/15Methods of treating skin disorders using il-31ra antagonist
07/16/15Polynucleotides encoding antagonists of il-17a, il-17f, and il-23p19
07/02/15Method of treating pruritus with il-31 monoclonal antibodies
07/02/15Variable region sequences of il-31 monoclonal antibodies and methods of use
06/25/15B7 family member zb7h6 and related compositions and methods
06/04/15Compositions and methods for modulating immune responses
05/14/15Methods of treating neuronal inflammation using an il-31 monoclonal antibody
05/14/15Methods of antagonizing signal transduction in spinal cord cells using an il-31ra or osmr-b antagonist
02/05/15Il-31 monoclonal antibodies
01/15/15Combination of blys and/or april inhibition and immunosuppressants for treatment of autoimmune disease
01/08/15Homogeneous preparations of il-31
01/08/15Methods of treating inflammatory diseases using antibodies that bind both il-17a and il-17f
01/08/15Polynucleotides encoding zcytor17 ligand antibodies
09/18/14Method for treating inflammation
09/04/14Zcytor19 polynucleotides, polypeptides, antibodies and methods of use
08/07/14Levels of bcma protein expression on b cells and use in diagnostic methods
07/03/14Methods of treating pain using an il-31ra or osmr-b antagonist
07/03/14Polynucleotides encoding il-31 monoclonal antibodies
06/26/14Homogenous preparations of il-28 and il-29
05/22/14Zcytor17 heterodimeric cytokine receptor
05/08/14Methods of treating pain using an il-31 monoclonal antibody
04/17/14Soluble hybrid fcgamma receptors and related methods
03/20/14Polynucleotides encoding il-31 monoclonal antibodies
02/13/14Use of truncated cysteine il28 and il29 mutants to treat cancers and autoimmune disorders
01/02/14Method for treating cervical cancer
12/12/13Anti-il-tif antibodies
12/12/13Levels of blys/april heterotrimers in serum and use in diagnostic methods
11/28/13Anti-il-22ra antibodies
11/21/13Methods for using taci-immunoglobulin fusion proteins
11/21/13Antagonists of il-17a, il-17f, and il-23p19
11/14/13Cytokine zalpha11 ligand
10/17/13Methods for treating viral infection using il-28 and il-29
08/22/13Variable region sequences of il-31 monoclonal antibodies and methods of use
08/15/13Method of treating fibroproliferative disorders
Patent Packs
08/15/13Antibodies that bind both il-17a and il-17f and methods of using the same
08/08/13Methods of using il-31 antagonists in diseases mediated by cutaneous lymphocyte antigen positive t cells
08/01/13Methods of antagonizing signal transduction in dorsal root ganglion cells
07/11/13Methods of treating diseases which are mediated by cutaneous lymphocyte antigen positive cells
07/04/13Soluble interleukin-20 receptor
06/20/13Use of zcytor17 ligand antagonists for treating inflammatory diseases
06/13/13Homogeneous preparations of il-31
06/06/13Antibody to human zcyto-10 polypeptide
06/06/13Zcytor17 heterodimeric cytokine receptor polynucleotides
04/18/13Dimeric fusion proteins and related compositions and methods
02/14/13Polynucleotides encoding antibodies to cytokine receptor zcytor17
01/31/13Methods of treating il-tif associated inflammatory or immune diseases using antibodies against soluble zcytor 11 cytokine receptors
01/24/13Method of treating fibroproliferative disorders
12/27/12Polynucleotides encoding antibodies that bind both il-17a and il-17f
11/22/12Methods of treating cancer using il-21
Patent Packs
11/22/12Antagonists of il-17a, il-17f, and il-23p19
11/22/12Nucleic acids encoding anti-il-23 antibodies
11/15/12Methods of treating inflammation using soluble il-17ra/rc fusion proteins
11/08/12Il-21 antagonists
10/25/12Production and purification of il-29
10/18/12Zcytor17 heterodimeric cytokine receptor polynucleotides
10/11/12Interferon-like protein zcyto21
10/04/12Use of truncated cysteine il28 and il29 mutants to treat cancers and autoimmune disorders
09/06/12Anti-human il-21 monoclonal antibodies
08/16/12Methods of antagonizing signal transduction in spinal cord cells
08/16/12Anti-il-22ra antibodies and binding partners and methods of using in inflammation
08/16/12Methods for detecting modulators of cytokine receptor zalpha11
08/16/12Cytokine zalpha11 ligand
07/26/12Anti-il-tif antibodies and methods of using in inflammation
07/12/12Antibodies that bind both il-17a and il-17f and methods of using the same
07/12/12Anti-human il-21 monoclonal antibodies
06/21/12Anti-il-tif antibodies and methods of use
06/21/12Methods of treatment using anti-il-22ra antibodies
06/07/12Cytokine protein family
05/31/12Compositions and methods for using multispecific-binding proteins comprising an antibody-receptor combination
05/10/12Il28 and il29 truncated cysteine mutants and antiviral methods of using same
05/03/12Methods of antagonizing signal transduction in spinal cord cells
04/12/12Method for treating inflammation
04/05/12Soluble il-17ra/rc fusion proteins and related methods
04/05/12Human cytokine receptor
04/05/12Methods of using il-31 to treat chronic obstructive pulmonary disease (copd)
03/15/12Zcytor19 polynucleotides, polypeptides, antibodies and methods of use
03/01/12Zcytor19 heterodimeric cytokine receptor polynucleotides, polypeptides, antibodies and methods
02/09/12Antibodies that bind both bcma and taci
02/09/12Interferon-like protein zcyto21
Social Network Patent Pack
01/26/12Methods for treating viral infection using il-28 and il-29
01/26/12Growth factor homolog zvegf4
01/19/12Production and purification of il-29
01/05/12Homogenous preparations of il-28 and il-29
12/29/11Antibodies that bind both il-17a and il-17f and methods of using the same
12/29/11Cytokine receptor zcytor17 multimers
12/08/11Methods for treating viral infection using il-28 and il-29 cysteine mutants
12/08/11Methods of treating cancer using il-21 and monoclonal antibody therapy
12/01/11Methods of using il-31 monoclonal antibodies to reduce inflammation
11/24/11Nucleic acid encoding cytokine receptor zcytor17
Patent Packs
10/27/11Single chain fc type iii interferons and methods of using same
09/22/11Methods for using taci-immunoglobulin fusion proteins
08/11/11Cytokine protein family
08/11/11Murine zcytor17 ligand polynucleotides
08/04/11Methods for soluble zalpha11 cytokine receptors
07/28/11Methods for detecting modulators of cytokine receptor zalpha11
07/21/11Use of truncated cysteine il28 and il29 mutants to treat cancers and autoimmune disorders
07/21/11Methods of treating inflammation in neuronal tissue
07/21/11Soluble zcytor14, anti-zcytor14 antibodies and binding partners and methods of using in inflammation
07/21/11Methods of antagonizing signal transduction in dorsal root ganglion cells
07/14/11Zcytor19 heterodimeric cytokine receptor polynucleotides, polypeptides, antibodies and methods
07/14/11Il-21 antagonists
07/07/11Medical devices for delivering fluids during surgery and methods for their use
06/30/11Methods of inhibiting inflammation with antagonists to il-17a, il-17f, and il-23p19
06/23/11Soluble heterodimeric cytokine receptor
06/23/11Methods of purifying zsig33
06/23/11Thrombin activator compositions and methods of making and using the same
06/02/11Anti-human il-21 monoclonal antibodies
05/26/11Hemostatic microspheres
05/19/11Methods of treatment using il-31ra
05/12/11Soluble receptor br43x2 and methods of using
05/12/11Soluble receptor br43x2 and methods of using
04/28/11Antibodies that bind both il-17a and il-17f and methods of using the same
04/14/11Methods of treating cancer using il-21 and monoclonal antibody therapy
04/07/11Methods for treating disease using an anti-il-21 receptor antibody
04/07/11Soluble zcytor 11 cytokine receptors
04/07/11B7 family member zb7h6 and related compositions and methods
03/31/11Method for treating inflammation
03/10/11Il-17 and il-23 antagonists and methods of using the same
03/03/11Method of treating hepatocellular carcinoma
Patent Packs
03/03/11Polynucleotides encoding class ii cytokine receptor-7
02/03/11Soluble interleukin-20 receptor
01/20/11Soluble il-17ra/rc fusion proteins and related methods
01/13/11Methods for treating viral infection using il-28 and il-29 cysteine mutants
01/13/11Methods of determining dose of il-31 agonist to treat pulmonary inflammation
01/06/11Methods of treating cancer using il-21
12/23/10Methods of treating cancer using il-21
12/16/10Methods of treating cancer using il-21
12/16/10Methods of treating cancer using il-21
12/16/10Methods of treating cancer using il-21
12/16/10Compositions and methods for modulating immune responses
12/09/10Methods of treating cancer using il-21
12/09/10Methods of using il-21 for adoptive immunotherapy and identification of tumor antigens
12/09/10Antibodies that bind both il-17a and il-17f and methods of using the same
12/09/10Human cytokine receptor
11/25/10Cytokine zalpha11 ligand antibodies
11/25/10Cytokine zalpha11 ligand antibodies
11/25/10Homogeneous preparations of il-31
11/25/10Methods for treating viral infection using il-28 and il-29
11/25/10Methods of treating pain using antagonists of il-31, il-31ra and/or osmrb
Social Network Patent Pack
11/25/10Trimerizing polypeptides
11/25/10Use of truncated cysteine il28 and il29 mutants to treat cancers and autoimmune disorders
11/25/10Mammalian zcytor 11
11/18/10Methods of using il-21
11/18/10Method of treating fibrproliferative disorders
11/18/10Pharmaceutical composition comprising fgf18 and il-1 antagonist and use
11/18/10Use of human cytokine receptor
10/21/10Cytokine receptor zcytor17 multimers
10/21/10Cytokine receptor zcytor17 multimers
09/09/10A using interferon-like potein zcyto20 (il-28a) or zcyto22(il-28b) to treat hepatitis b
09/02/10Antagonizing signal transduction in dorsal root ganglion cells in a subject with il-31 antagonists
09/02/10A using interferon-like protein zcyto21(il-29) to treat hepatitis b
09/02/10Antibodies to cytokine receptor zalpha11
09/02/10Cytokine zalpha11ligand antibodies
08/19/10Anti-il-22ra antibodies and binding partners and methods of using in inflammation
08/05/10Soluble interleukin-20 receptor
08/05/10Antibodies to human tumor necrosis factor receptor
07/22/10Taci-immunoglobulin fusion proteins
07/01/10Growth factor homolog zvegf3
05/27/10Taci-immunoglobulin fusion proteins
Social Network Patent Pack
05/27/10Taci-immunoglobulin fusion proteins
05/06/10Anti-il-22ra antibodies and binding partners and methods of using in inflammation
05/06/10Anti-il-20, anti-il-22 and anti-il-22ra antibodies and binding partners and methods of using in inflammation
05/06/10Soluble il-17rcx4 and methods of using in inflammation
04/22/10Polynucleotides encoding class ii cytokine receptor-7
04/22/10Interleukin-17 receptor homologue
04/22/10Human cytokine receptor
04/01/10Anti-il-tif antibodies and methods of use
03/25/10Methods for soluble zalpha11 cytokine receptors
03/25/10Antibodies to mammalian cytokine-like factor 7
03/04/10Mammalian zcytor 11
03/04/10Cytokine receptor zcytor17 multimers
02/25/10Soluble zcytor 11 cytokine receptors
01/21/10Antibody to mammalian cytokine-like polypeptide-10
01/14/10Methods for treating disease using an anti-il-21 receptor antibody
12/17/09Method for treating cervical cancer
11/19/09Treatment of wounds using il-17b
11/19/09Use of interleukin-19 to treat cervical cancer
11/19/09Medicament and a treating a pathological syndrome
11/12/09Methods of treating diseases which are mediated by cutaneous lymphocyte antigen positive cells
11/12/09Materials and methods for preparing dimeric growth factors
11/05/09Cytokine receptor zcytor17 multimers
11/05/09Il-31 receptor antibodies
11/05/09Levels of blys/april heterotrimers in serum and use in diagnostic methods
10/29/09Methods of treating cancer using il-21 and monoclonal antibody therapy
10/29/09Methods of using motilin homologs
10/22/09Use of blood coagulation factor xiii for treating hemophilia a
10/22/09Human cytokine receptor
10/08/09Methods of treating skin disorders using an il-31ra antagonist
10/08/09Growth factor homolog zvegf4
Social Network Patent Pack
09/10/09Growth factor homolog zvegf4
09/03/09Methods of using il-31 monoclonal antibodies to reduce inflammation
09/03/09Anti-il-22ra antibodies and binding partners and methods of using in inflammation
08/20/09Taci-immunoglobulin fusion proteins
08/13/09Methods of treating infections using il-21
08/06/09Methods of producing antibodies to zalpha11 cytokine receptors
07/30/09Methods of treating infections using il-21
07/30/09Production of homotrimeric fusion proteins
07/30/09Murine zcytor17 ligand polypeptides and polynucleotides
07/23/09Antibodies that bind both bcma and taci
07/09/09Methods of using phhla2 to co-stimulate t-cells
06/18/09Il-17a and il-17f antagonists and methods of using the same
06/18/09Methods of using antibodies that bind both bcma and taci
06/18/09Compositions and methods for modulating immune responses
06/18/09Zsig33-like polynucleotides
06/11/09Antibodies to human zcytor17 ligand
06/11/09Cytokine protein family
04/23/09Mass spectrometry-based quantitative assay for determining abundance of molecular species in a composition
04/09/09Antibodies that bind both bcma and taci
04/09/09Antibodies that bind both bcma and taci
04/09/09Methods of predicting therapeutic response in atopic dermatitis to il-31 antagonists
04/02/09Methods of treating cancer using il-21 and monoclonal antibody therapy
03/26/09Method of forming a peptide-receptor complex with zsig33
03/19/09Dimeric fusion proteins and materials and methods for producing them
03/19/09Anti-il-22ra antibodies and binding partners and methods of using in inflammation
03/19/09Antibodies to class ii cytokine receptor-7
03/19/09Il-21 antagonists
03/12/09Interferon-like protein zcyto21
02/05/09Use of blood coagulation factor xiii for treating hemophilia a







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Zymogenetics Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Zymogenetics Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';